Mucovagin vaginal globules is the first preparation in Poland containing specially formulated hyaluronic acid of small-molecule structure - BASHYAL™. Mucovagin supports healing processes and regeneration of the vaginal mucosa. It is recommended especially in the states of vaginal atrophy and dystrophy. It facilitates treatment and wound healing after childbirth and gynaecological surgery. It soothes inflammation and reduces discomfort caused by dryness of the vaginal mucosa as a result of menopause.
Intended for use:
Hyaluronic acid, which is a natural building block of the human body, is an active ingredient of the Mucovagin vaginal globules. Binding to moist mucous secretions of a vagina, the hyaluronic acid forms a Gel coating on its surface. It constitutes a protective barrier caring for mucous membrane and creating appropriate conditions for activation of natural regeneration and defence mechanisms. In this manner, the protective film prevents the growth of pathogenic flora, restores natural moisture, facilitates and speeds up healing processes.
5 mg of hyaluronic acid - small-molecule BASHYAL™
The product does not contain hormones, parabens, oils, plant extracts, and fragrances
During standard therapy it is recommended to use 1 vaginal globule per day, at bedtime or as directed by your doctor.
Packaging: 10 vaginal globules
 The effectiveness of Mucovagin vaginal globules in the treatment of patients with symptoms of vaginal dryness" Dr. Ewa Kurowska; Analysis of the cases in gynecology and obstetrics
 Test in vitro performed by Soliance and Uniwersite Paris 5, Kamelia Ghazi Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight – Kamelia Ghazi et al. 2012
Mucovagin Gel contains hyaluronic acid with unique, small-molecule structure - BASHYAL™. Mucovagin supports healing processes and regeneration of the vaginal mucosa. It is recommended especially in the states of vaginal atrophy and dystrophy. It facilitates treatment and wound healing after childbirth and gynaecological surgery. It soothes inflammation and reduces the discomfort caused by dryness of the vaginal mucosa during menopause. Gel form allows for dual application: vaginal and onto external intimate parts.
Intended for use:
Hyaluronic acid, which is a natural building block of the human body, is an active ingredient of the Mucovagin Gel. Binding to moist mucous secretions of the vagina, the hyaluronic acid forms a gel coating on its surface. It constitutes a protective barrier caring for mucous membrane and creates appropriate conditions for activation of natural regeneration and defence mechanisms. In this manner, the protective film prevents the growth of pathogenic flora, restores natural moisture, facilitates, and speeds up healing processes.
Small-molecule hyaluronic acid BASHYAL ™.
Does not contain hormones, parabens, oils, herbal extracts and fragrances
Mucovagin Gel should be used internally, topically into the vagina, or externally onto the genital area. Before and after use wash your hands thoroughly.
Mucovagin Gel is applied internally in the supine position, by means of the applicator attached to the package, which enables to use appropriate amount of the gel.
Apply a small amount of the product (the contents of the applicator) in the vicinity of the external genitalia.
Packaging: 25 g + 7 disposable applicators.
MUCOVAGIN physiological emulsion is a specialist physiological emulsion for daily female intimate hygiene, recommended especially for daily care during the regeneration of genital areas. It is recommended for use after giving birth and undergoing gynaecological procedures, including aesthetic gynaecology.
For daily care during the regeneration of genital areas:
After giving birth and undergoing gynaecological procedures, including aesthetic gynaecology, it is recommended to use MUCOVAGIN emulsion together with MUCOVAGIN vaginal globules or MUCOVAGIN gel with applicator. MUCOVAGIN (globules or gel) makes the healing and regeneration process easier and faster.
MUCOVAGIN emulsion is recommended for daily care during the regeneration process due to its carefully selected ingredients:
• It contains octenidine and BASHYAL™, a unique formula of fine hyaluronic acid
• The product has been gynecologically tested
• It does not contain preservatives*, soap, SLS or SLES
• It can be used by pregnant and breastfeeding women
Aqua, Decyl Glucoside, Glycerin, Cocamidopropyl Betaine, Macadamia Ternifolia Seed Oil, Cetyl Alcohol, Panthenol, Glyceryl Oleate, Cetearyl Alcohol, Allantoin, Sodium Hyaluronate, Xanthan Gum, Propylene Glycol, Ethylhexylglycerin, Octenidine HCl, Phenethyl Alcohol, Caprylyl Glycol, Lactic Acid.
Apply a little bit of the emulsion on your washed hand, dilute with some water, wash your intimate parts and rinse thoroughly with water.
After giving birth and undergoing gynaecological procedures, it is recommended to use MUCOVAGIN emulsion together with MUCOVAGIN vaginal globules or MUCOVAGIN gel with applicator. MUCOVAGIN (globules or gel) makes the healing and regeneration process easier and faster.
The product cannot be used by people allergic to any of its ingredients. Interactions with other products are not known. In case of irritation or allergic reaction, stop using the product.
Package: 150 ml
Dietary supplement for women Trivagin recommended with the aim of restore of normal bacterial flora. Each capsule contains 3 billion cells of the lactic acid bacteria.
The oral form of capsules and the fact that there is no need to store the product in the refrigerator provide convenience of usage and storage.
Intended for use:
The lactic acid bacteria are responsible for the maintenance of normal, acidic vaginal environment. Natural acidic vaginal environment is a prerequisite for the proper functioning of the genitourinary system.
Active ingredients The content in one capsule
Recommended daily intake: 1 capsule per day. Best
eaten during or after a meal with a small amount of water.
Trivagin gel helps treat intimate infections. It relieves the symptoms of bacterial and fungal infections, such as itching, burning, redness and irritation which occurs with leucorrhoea.
The medical device can be used as a supportive measure in the course of:
The product is intended for women and children above the age of 3.
Trivagin gel relieves symptoms of fungal and bacterial infections, such as itching, burning, redness and irritation which occurs with leucorrhoea.
It moisturizes and restores the natural safety barrier of your intimate parts, protecting them from the development of pathogenic flora.
It helps restore natural vaginal flora and maintains proper pH, which is responsible for developing a protective layer on your skin.
It eliminates the dryness of your skin and mucous membrane.
It doesn’t stain underwear and it doesn’t feel sticky. It’s easy to use.
Water, lauryl alcohol ethoxylate, glycerol, phenoxyethanol, acrylates/C10-30 alkyl acrylate crosspolymer, alpha glucan, triethanolamine, tetrasodium glutamate diacetate, ethylhexylglycerin, polysaccharides, sodium hyaluronate, lactic acid
Before you apply the gel, thoroughly wash and dry your intimate parts. Spread a thin layer of the gel on your external genitalia, starting from the front and moving in the direction of the anus. Use as needed, 2-3 times per day. Wash your hands thoroughly before and after applying the gel. The gel will not stain your underwear.
Package: 30 ml
For external use only. Do not apply on broken skin or if you are allergic to any ingredient of the product. No interaction with other medicines/medical devices was observed, but do not use other medicines/medical devices/liquids on your intimate parts for 30 minutes after you applied the product. Do not use after the expiry date. Do not use longer than 30 days after opening the package.
Trivagin gel medical device can only be used in accordance with directions for use. Full directions for use are available at www.trivagin.pl
Keep Trivagin gel in a dry place, in temperature below 25oC. Do not freeze the product and do not keep it in the fridge. Keep away from sunlight. Keep out of the reach of children.
 Application test results conducted on a group of 30 women. The preparation reduced or removed itching immediately or shortly after application.
OVARIN is a dietary supplement for women that contains carefully chosen nutrients which help maintain hormonal balance , in quantities adjusted to the needs of women of childbearing age.
Thanks to inositol, folic acid, vitamin D and B vitamins, Ovarin helps supplement your diet with ingredients of proven effectiveness
To maintain hormonal balance 
For women of childbearing age
Ovarin dietary supplement contains two isomeric forms of inositol: myo-inositol and D-chiro-inositol. Inositol is a vitamin-like substance which occurs naturally in your diet. Its absorption can be affected by poor eating habits, e.g. consuming too much coffee, tea and alcohol, but also by stress, antibiotics and hormonal contraception.
Folic acid participates in cell division, including the division of egg cells.Vitamin D in its recommended dose  participates in cell division. Pantothenic acid helps maintain proper energy metabolism, the synthesis and metabolism of steroid hormones, vitamin D and some neurotransmitters, whereas vitamin B6 regulates hormonal activity. Vitamin B12 helps maintain proper energy metabolism and proper functioning of the nervous system. Folic acid, vitamin B6 and vitamin B12 participate in maintaining proper metabolism of homocysteine.
per 1 tablet
per 2 tablets (daily dose)
200 µg (100% DRI)
400 µg (200% DRI)
12,5 µg - 500 IU (250% DRI)
25 µg - 1000 IU (500% DRI)
0,7 mg (50% DRI)
1,4 mg (100% DRI)
3 mg (50% DRI)
6 mg (100% DRI)
1,25 µg (50% DRI)
2,5 µg (100% DRI)
Recommended dose: 2 tablets a day.
Package: 60 tablets
 Pantothenic acid helps maintain proper energy metabolism, the synthesis and metabolism of steroid hormones, vitamin D and some neurotransmitters, whereas vitamin B6 regulates hormonal activity.
 Guidelines for vitamin D supplementation for Central Europe, recommended doses of vitamin D for the healthy population and groups of people at risk of vitamin D deficit, Endokrynologia Polska 2013; 64 (4).